Concomitant Use of Statins, Metformin, or Proton Pump Inhibitors in Patients with Advanced Renal Cell Carcinoma Treated with First-Line Combination Therapies.
Matteo SantoniJavier Molina-CerrilloZin W MyintFrancesco MassariTomas BuchlerSebastiano ButiMarc R MatranaUgo De GiorgiMimma RizzoIgnacio Ortego ZabalzaLuca GalliPaolo Andrea ZucaliGaetano AurilioLorena IncorvaiaMaria BassanelliGiulia MammoneAlessia SalfiLuca IsellaVeronica MollicaEnrique GrandeCamillo PortaNicola BattelliPublished in: Targeted oncology (2022)
Our study suggests a prognostic impact of statin use in patients receiving first-line immuno-oncology combinations. The mechanism of this interaction warrants further elucidation.